Analabs Resources Berhad Past Earnings Performance
Past criteria checks 2/6
Analabs Resources Berhad has been growing earnings at an average annual rate of 29.6%, while the Chemicals industry saw earnings growing at 1.6% annually. Revenues have been growing at an average rate of 7.3% per year. Analabs Resources Berhad's return on equity is 6.8%, and it has net margins of 20%.
Key information
29.6%
Earnings growth rate
29.6%
EPS growth rate
| Chemicals Industry Growth | 8.9% |
| Revenue growth rate | 7.3% |
| Return on equity | 6.8% |
| Net Margin | 20.0% |
| Last Earnings Update | 31 Jul 2024 |
Recent past performance updates
Recent updates
Does Analabs Resources Berhad (KLSE:ANALABS) Have A Healthy Balance Sheet?
Jan 04
Analabs Resources Berhad (KLSE:ANALABS) Is Due To Pay A Dividend Of MYR0.02
Feb 13Analabs Resources Berhad (KLSE:ANALABS) Is Doing The Right Things To Multiply Its Share Price
Mar 28Analabs Resources Berhad (KLSE:ANALABS) Has A Pretty Healthy Balance Sheet
Jan 21Here's Why Analabs Resources Berhad (KLSE:ANALABS) Can Manage Its Debt Responsibly
Sep 13Does Analabs Resources Berhad (KLSE:ANALABS) Have A Healthy Balance Sheet?
May 24Analabs Resources Berhad (KLSE:ANALABS) Might Be Having Difficulty Using Its Capital Effectively
Apr 28Here's Why We Think Analabs Resources Berhad (KLSE:ANALABS) Is Well Worth Watching
Apr 07Could Analabs Resources Berhad (KLSE:ANALABS) Have The Makings Of Another Dividend Aristocrat?
Mar 17Should You Buy Analabs Resources Berhad (KLSE:ANALABS) For Its Upcoming Dividend?
Feb 19Does Analabs Resources Berhad (KLSE:ANALABS) Have A Healthy Balance Sheet?
Feb 09
Is Analabs Resources Berhad (KLSE:ANALABS) Set To Make A Turnaround?
Jan 14Is Analabs Resources Berhad (KLSE:ANALABS) An Attractive Dividend Stock?
Dec 07Revenue & Expenses Breakdown
How Analabs Resources Berhad makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Jul 24 | 146 | 29 | 11 | 0 |
| 30 Apr 24 | 152 | 28 | 11 | 0 |
| 31 Jan 24 | 158 | 35 | 7 | 0 |
| 31 Oct 23 | 154 | 33 | 7 | 0 |
| 31 Jul 23 | 145 | 31 | 10 | 0 |
| 30 Apr 23 | 133 | 28 | 11 | 0 |
| 31 Jan 23 | 125 | 12 | 18 | 0 |
| 31 Oct 22 | 123 | 21 | 18 | 0 |
| 31 Jul 22 | 116 | 23 | 15 | 0 |
| 30 Apr 22 | 116 | 29 | 14 | 0 |
| 31 Jan 22 | 120 | 29 | 13 | 0 |
| 31 Oct 21 | 119 | 24 | 12 | 0 |
| 31 Jul 21 | 117 | 19 | 12 | 0 |
| 30 Apr 21 | 117 | 16 | 13 | 0 |
| 31 Jan 21 | 108 | 13 | 14 | 0 |
| 31 Oct 20 | 105 | 9 | 14 | 0 |
| 31 Jul 20 | 109 | 9 | 14 | 0 |
| 30 Apr 20 | 111 | 7 | 15 | 0 |
| 31 Jan 20 | 109 | 5 | 15 | 0 |
| 31 Oct 19 | 112 | 5 | 16 | 0 |
| 31 Jul 19 | 122 | 5 | 16 | 0 |
| 30 Apr 19 | 130 | 4 | 17 | 0 |
| 31 Jan 19 | 136 | 8 | 4 | 0 |
| 31 Oct 18 | 142 | 10 | 8 | 0 |
| 31 Jul 18 | 136 | 9 | 12 | 0 |
| 30 Apr 18 | 138 | 9 | 17 | 0 |
| 31 Jan 18 | 145 | 9 | 14 | 0 |
| 31 Oct 17 | 144 | 9 | 15 | 0 |
| 31 Jul 17 | 148 | 11 | 17 | 0 |
| 30 Apr 17 | 150 | 11 | 19 | 0 |
| 31 Jan 17 | 158 | 12 | 22 | 0 |
| 31 Oct 16 | 155 | 13 | 23 | 0 |
| 31 Jul 16 | 158 | 14 | 24 | 0 |
| 30 Apr 16 | 155 | 13 | 24 | 0 |
| 31 Jan 16 | 151 | 12 | 24 | 0 |
| 31 Oct 15 | 153 | 9 | 26 | 0 |
| 31 Jul 15 | 143 | 7 | 23 | 0 |
| 30 Apr 15 | 142 | 7 | 23 | 0 |
| 31 Jan 15 | 135 | 6 | 51 | 0 |
| 31 Oct 14 | 136 | 8 | 38 | 0 |
| 31 Jul 14 | 140 | 8 | 28 | 0 |
| 30 Apr 14 | 140 | 10 | 18 | 0 |
| 31 Jan 14 | 146 | 11 | 18 | 0 |
Quality Earnings: ANALABS has high quality earnings.
Growing Profit Margin: ANALABS's current net profit margins (20%) are lower than last year (21.3%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: ANALABS's earnings have grown significantly by 29.6% per year over the past 5 years.
Accelerating Growth: ANALABS's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: ANALABS had negative earnings growth (-4.9%) over the past year, making it difficult to compare to the Chemicals industry average (24.9%).
Return on Equity
High ROE: ANALABS's Return on Equity (6.8%) is considered low.
Return on Assets
Return on Capital Employed
Discover strong past performing companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/21 06:54 |
| End of Day Share Price | 2024/12/19 00:00 |
| Earnings | 2024/07/31 |
| Annual Earnings | 2024/04/30 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Analabs Resources Berhad is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|